Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vitro anti-Leishmania activity and molecular docking of spiro-acridine compounds as potential multitarget agents against Leishmania infantum
Fernanda Silva Almeida, Gleyton Leonel Silva Sousa, Juliana C. Rocha, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 49, pp. 128289-128289
Closed Access | Times Cited: 17

Showing 17 citing articles:

Synthetic product-based approach toward potential antileishmanial drug development
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115927-115927
Closed Access | Times Cited: 18
Natural-Product-Inspired Microwave-Assisted Synthesis of Novel Spirooxindoles as Antileishmanial Agents: Synthesis, Stereochemical Assignment, Bioevaluation, SAR, and Molecular Docking Studies
Nawal Kishore Sahu, Ritu Sharma, Kshirsagar Prasad Suhas, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4817-4817
Open Access | Times Cited: 11
Targeting Cysteine Protease B to Discover Antileishmanial Drugs: Directions and Advances
Esteban F. Rios, Sonaly Lima Albino, Ricardo Olímpio de Moura, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117500-117500
Closed Access
Regioselective cyclocondensations with thiobarbituric acid: spirocyclic and azocine products, X-ray characterization, and antioxidant evaluation
Efraín Polo-Cuadrado, Karen Acosta-Quiroga, Cristian Rojas-Peña, et al.
RSC Advances (2025) Vol. 15, Iss. 11, pp. 8609-8621
Open Access
Study of the Antileishmanial Activity of Novel Guanidine and Hybrid Acridine – Guanidine Compounds
Luana Ribeiro dos Anjos, J. C. R. de Souza, André Luis Souza dos Santos, et al.
European Journal of Medicinal Chemistry (2025), pp. 117651-117651
Closed Access
Spiro heterocycles bearing piperidine moiety as potential scaffold for antileishmanial activity: synthesis, biological evaluation, and in silico studies
Mounir A. A. Mohamed, Asmaa M. Kadry, Salma A. Bekhit, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 330-342
Open Access | Times Cited: 14
Apoptotic and antioxidant effects in HCT-116 colorectal carcinoma cells by a spiro-acridine compound, AMTAC-06
Sâmia Sousa Duarte, Daiana Karla Frade Silva, Thaís Mangeon Honorato Lisboa, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 3, pp. 545-554
Closed Access | Times Cited: 12
ACW-02 an Acridine Triazolidine Derivative Presents Antileishmanial Activity Mediated by DNA Interaction and Immunomodulation
Sonaly Lima Albino, Willian Charles da Silva Moura, Malu Maria Lucas dos Reis, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 204-204
Open Access | Times Cited: 7
Scaffold repositioning of spiro-acridine derivatives as fungi chitinase inhibitor by target fishing and in vitro studies
Jéssika de Oliveira Viana, Eden Silva e Souza, Nicolau Sbaraini, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
A Core‐Linker‐Polyamine (CLP) Strategy Enables Rapid Discovery of Antileishmanial Aminoalkylquinolinecarboxamides That Target Oxidative Stress Mechanism
Archana P. Shah, Neha Hura, Neerupudi Kishore Babu, et al.
ChemMedChem (2022) Vol. 17, Iss. 16
Closed Access | Times Cited: 7
Diastereoselective Construction of CF3‐Containing Bispiro[isoquinolone‐pyrrolidine‐benzothiophenone]s through 1,3‐Dipolar Cycloaddition
Cheng Niu, Da‐Ming Du
European Journal of Organic Chemistry (2022) Vol. 2022, Iss. 26
Closed Access | Times Cited: 3
Demystifying the potential of inhibitors targeting DNA topoisomerases in unicellular protozoan parasites
Swati Lamba, Amit Roy
Drug Discovery Today (2023) Vol. 28, Iss. 6, pp. 103574-103574
Closed Access | Times Cited: 1
Spiro‐Acridine Compound as a Pteridine Reductase 1 Inhibitor: in silico Target Fishing and in vitro Studies
Jéssika de Oliveira Viana, Marina Sena Mendes, Marcelo Santos Castilho, et al.
ChemMedChem (2024) Vol. 19, Iss. 11
Closed Access
Antileishmanial activity of essential oil from a high-altitude herb, Heracleum pinnatum : an in vitro and in silico analysis
Rigzin Chuskit, J. Joshi, Ipsa Gupta, et al.
Journal of Essential Oil Bearing Plants (2024) Vol. 27, Iss. 3, pp. 818-837
Closed Access
Microwave Facilitated Discovery of Substituted 1,2,4-triazaspiro[4.5] dec-2-en-3-amines: Biological and Computational Investigations
Parth P. Patel, Navin B. Patel, Manesh S. Tople, et al.
Current Microwave Chemistry (2023) Vol. 10, Iss. 2, pp. 208-222
Closed Access
Target-Based Rational Improvement Strategies and Pitfalls in Leishmania Drug Discovery
Yash Gupta, Steven Goicoechea, Jesse Vance, et al.
(2023), pp. 329-383
Closed Access
Identification of spiro-acridine derivatives as fungi chitinase inhibitor by target fishing and in vitro studies
Jéssika de Oliveira Viana, Eden Silva e Souza, Nicolau Sbaraini, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top